These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21426177

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Assembly system of direct modified superparamagnetic iron oxide nanoparticles for target-specific MRI contrast agents.
    Tanaka K, Kitamura N, Morita M, Inubushi T, Chujo Y.
    Bioorg Med Chem Lett; 2008 Oct 15; 18(20):5463-5. PubMed ID: 18829309
    [Abstract] [Full Text] [Related]

  • 23. Magnetic resonance imaging enhancement of normal tissues and tumors using macromolecular Gd-based cascade polymer contrast agents: preclinical evaluations.
    Raatschen HJ, Fu Y, Shames DM, Wendland MF, Brasch RC.
    Invest Radiol; 2006 Dec 15; 41(12):860-7. PubMed ID: 17099424
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
    Ahrén M, Selegård L, Klasson A, Söderlind F, Abrikossova N, Skoglund C, Bengtsson T, Engström M, Käll PO, Uvdal K.
    Langmuir; 2010 Apr 20; 26(8):5753-62. PubMed ID: 20334417
    [Abstract] [Full Text] [Related]

  • 27. The behavior after intravenous injection in mice of multiwalled carbon nanotube / Fe3O4 hybrid MRI contrast agents.
    Wu H, Liu G, Zhuang Y, Wu D, Zhang H, Yang H, Hu H, Yang S.
    Biomaterials; 2011 Jul 20; 32(21):4867-76. PubMed ID: 21459436
    [Abstract] [Full Text] [Related]

  • 28. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
    Mulder WJ, Strijkers GJ, van Tilborg GA, Griffioen AW, Nicolay K.
    NMR Biomed; 2006 Feb 20; 19(1):142-64. PubMed ID: 16450332
    [Abstract] [Full Text] [Related]

  • 29. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J, Sammet S, Yang X, Jia G, Takayama Y, Knopp MV.
    Invest Radiol; 2010 May 20; 45(5):233-44. PubMed ID: 20351653
    [Abstract] [Full Text] [Related]

  • 30. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
    Aime S, Castelli DD, Crich SG, Gianolio E, Terreno E.
    Acc Chem Res; 2009 Jul 21; 42(7):822-31. PubMed ID: 19534516
    [Abstract] [Full Text] [Related]

  • 31. A novel hybrid carbon material.
    Nasibulin AG, Pikhitsa PV, Jiang H, Brown DP, Krasheninnikov AV, Anisimov AS, Queipo P, Moisala A, Gonzalez D, Lientschnig G, Hassanien A, Shandakov SD, Lolli G, Resasco DE, Choi M, Tománek D, Kauppinen EI.
    Nat Nanotechnol; 2007 Mar 21; 2(3):156-61. PubMed ID: 18654245
    [Abstract] [Full Text] [Related]

  • 32. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y, Raatschen HJ, Nitecki DE, Wendland MF, Novikov V, Fournier LS, Cyran C, Rogut V, Shames DM, Brasch RC.
    Biomacromolecules; 2007 May 21; 8(5):1519-29. PubMed ID: 17402781
    [Abstract] [Full Text] [Related]

  • 33. Chemistry of paramagnetic and diamagnetic contrast agents for Magnetic Resonance Imaging and Spectroscopy pH responsive contrast agents.
    Pérez-Mayoral E, Negri V, Soler-Padrós J, Cerdán S, Ballesteros P.
    Eur J Radiol; 2008 Sep 21; 67(3):453-8. PubMed ID: 18455343
    [Abstract] [Full Text] [Related]

  • 34. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC, Fauda V, Scaramuzza D, Vergnaghi D.
    Radiol Med; 2000 Sep 21; 100(3):160-7. PubMed ID: 11148882
    [Abstract] [Full Text] [Related]

  • 35. Aggregation studies of the water-soluble gadofullerene magnetic resonance imaging contrast agent: [Gd@C82O6(OH)16(NHCH2CH2COOH)8]x.
    Shu CY, Zhang EY, Xiang JF, Zhu CF, Wang CR, Pei XL, Han HB.
    J Phys Chem B; 2006 Aug 10; 110(31):15597-601. PubMed ID: 16884284
    [Abstract] [Full Text] [Related]

  • 36. Iron oxide MR contrast agents for molecular and cellular imaging.
    Bulte JW, Kraitchman DL.
    NMR Biomed; 2004 Nov 10; 17(7):484-99. PubMed ID: 15526347
    [Abstract] [Full Text] [Related]

  • 37. Molecular magnetic resonance imaging with targeted contrast agents.
    Artemov D.
    J Cell Biochem; 2003 Oct 15; 90(3):518-24. PubMed ID: 14523986
    [Abstract] [Full Text] [Related]

  • 38. In vivo visualization of macrophage infiltration and activity in inflammation using magnetic resonance imaging.
    Beckmann N, Cannet C, Babin AL, Blé FX, Zurbruegg S, Kneuer R, Dousset V.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009 Oct 15; 1(3):272-98. PubMed ID: 20049797
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MRI contrast agents: basic chemistry and safety.
    Hao D, Ai T, Goerner F, Hu X, Runge VM, Tweedle M.
    J Magn Reson Imaging; 2012 Nov 15; 36(5):1060-71. PubMed ID: 23090917
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.